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Is There a Way Out of this Clinic? An Adult 
and Community Education Perspective 




This paper critically examines methadone treatment from the perspective of adult 
and community education and questions the absence of rehabilitation. It identifies 
biomedicine and the methodology of evidence based medicine as the discourses that 
determine our understanding of addiction and treatment. It is especially critical of 
psychiatry for the over medicalisation of addiction treatment and the communities 
uncritical acceptance of the assumptions of medicine. The paper then looks at the 
Crinan project, as a model of good practice in drug treatment and asks what makes 
adult and community education an effective component of treatment that works 
uniquely in a way that medical model does not? 
Introduction 
“Every revolution evaporates and leaves behind only the slime of a new bureau-
cracy”, (Kafka, cited in Preece, 2002, p.89). It too seemed like a revolution when 
in 1996 drug treatment, in the form of methadone maintenance, became more 
widely available in Dublin, after local protests about the increased number of 
drug related deaths among young people, during a time now referred to as the 
second heroin ‘epidemic’. The protests allowed the community to reclaim the 
streets as the heroin dealers were driven underground. The drug dealers, many 
of whom were heroin users themselves, did not go away and with the advent 
of the mobile phone they found new ways to sell heroin. Methadone clinics 
became key locations where drugs were bought and sold. Like the dealers, the 
epidemic did not go away either, as deaths associated with methadone became 
a feature of the drug problem. The new epidemic was a silent one. Death from 
a prescribed drug has a different impact. Drug users die silently from the long-
term side effects of poly drug use, prescribed and un-prescribed and after years 
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of multiple failed or ineffective treatment episodes. The cause of death is often 
blamed on the drug users for their moral failure, diseased brain, flawed genetics 
and inability to remain drug free while on methadone. 
Ten years later, methadone may have silenced the protesters and calmed the fears 
associated with HIV infection, but it has done little to help the majority of her-
oin addicts move out of the cycle of addiction. The drug problem has deepened 
over the intervening period and while today thousands of addicts can avail of 
methadone, there is widespread frustration in local communities about the lack 
of rehabilitation. Methadone promised to reduce drug related crime associated 
with the demand for heroin and yet, despite the availability of methadone, the 
demand for heroin remains. Heroin related prosecutions have increased sig-
nificantly from 296 in 1995 to 778 in 2004 (Connolly, 2006). Alcohol, cannabis, 
cocaine and benzodizaphine use are widespread among patients on methadone 
and there are new fears associated with the introduction of crystalmeth, a new 
and even more dangerous substance. 
The new bureaucracy left behind in the wake of this treatment revolution, has 
created a huge network of local drug task forces, national organisations and 
committees, professional bodies and local communities at an estimated cost of 
70 million euro annually. The key positions within this new bureaucracy are 
held by consultant psychiatrists who effectively control every aspect of addic-
tion treatment in Ireland. Underpinned by the powerful discourse of medi-
cine, psychiatrists exert enormous control and influence over the management, 
delivery and evaluation of methadone treatment programmes. 
Adult and community education; an emerging discourse in   
drug treatment.
The drug treatment centre or clinic is not a site usually frequented by research-
ers from the adult education tradition and yet it is a research site with pro-
found consequences for personal learning and development, conscientization, 
empowerment and social change. It is also a site that reflects disturbing inequal-
ities, injustice, oppression and individual suffering within society. Equally, it is 
a site inhabited by powerful professionals with competing interests that include 
patient care, publishing research, continuous professional development, main-
taining the status quo and sometimes, career progression. 
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Rooted in the tradition of conscientization (Freire, 1972), adult and commu-
nity education helps us to unmask oppressive power, overcome alienation and 
engage learners in a process of liberation. Freire believed the role of education 
was to liberate people from systematic oppression. The conscientization of 
methadone patients involves connecting them with the hidden curriculum that 
has shaped their addiction and now shapes their treatment. The hopes of meth-
adone patients should not be limited by lifelong treatment but instead should 
be transformed through a process of lifelong learning, leading them away from 
dependency toward liberation. The methadone patient as a lifelong learner 
is encouraged to become a critically reflexive and politicised human subject 
(Ryan, 2004).
This analysis is also rooted in a radical philosophy of adult education that seeks 
to challenge dominant ideologies, contest hegemony and resist discourses of 
domination that bolster the position and power of elite groups at the expense 
of others. Supported also by critical theory, adult education engages in a pro-
cess of examining how meanings are constructed through the socio-historical 
structures in society and looks at how individuals and groups re-constitute rela-
tions and the social world in every day life (Hyde, Lohan and McDonnell, 2004).
Critical theory has been particularly useful in examining discourses, seeing 
them as historically, socially and institutionally constructed statements, beliefs 
and practices that we take for granted (Ryan, 2004). They do not simply reflect 
or describe reality, but play an integral part in constructing it (Lupton, 1998).
Turner (1987) examined the biomedical discourse and underlined the relations 
that exist between medical practices and institutions, and the distribution of 
power and resources in contemporary societies. He suggested that biomedicine 
has created an unhealthy reliance on drugs and doctors, as well as a question-
able use of resources in healthcare systems.
Illich (1976) suggested that medicine was contributing to the growth in iat-
rogenic diseases. These are diseases caused by the excessive use of medicine. 
Treatment services for heroin addicts in Ireland, have become overly reliant on 
the use of methadone and other drugs as the primary solution, to what is fun-
damentally a social problem. The continued medicalisation of heroin addic-
tion is unsustainable. Increasing the numbers of people on methadone, without 
investing in sustainable rehabilitative pathways to facilitate people eventually 
detoxifying and exiting methadone treatment, may in fact be increasing the 
harm caused to society. Within communities affected by the drug problem, 
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there is a subdued acceptance that methadone is not as effective as the evidence 
suggests, in helping people move out of the cycle of addiction. More and more 
people are becoming trapped in the cycle of methadone treatment because of 
the insufficient number of rehabilitation pathways. The cost effectiveness of 
committing resources to the provision of methadone without a proper reha-
bilitative infrastructure must be questioned. Political leaders have generally not 
encouraged or participated in explicit debate about methadone or other harm 
reduction measures (Butler and Mayock, 2006). The psychiatrists dominate 
the debate through research published in medical and academic journals. The 
government in turn trusts the psychiatrists and the research they generate to 
support the efficacy of methadone. In the absence of sufficient research trans-
parency and the gap between the evidence and the reality on the ground, there 
is a need for a closer and more independent examination of methadone mainte-
nance treatment programmes as they operate in Ireland.
Psychiatrists cannot be blamed for all the problems associated with metha-
done or the lack of alternative and sustainable rehabilitative pathways out of 
addiction. They are a highly committed group of professionals contributing to 
solving the drug problem and, for the most part, work collaboratively with com-
munities and other professions. It is in their interest to see people recover from 
dependency and move beyond methadone and into rehabilitation. The com-
munity and voluntary sector must share some responsibility for where we are 
today in relation to drug treatment. The social analysis of the structural causes 
of poverty, unemployment and drug addiction may have been effective in a pre-
Celtic Tiger economy but ‘the rising tide’, has not raised all boats equally. The 
social analysis of the 1980s and 1990s on its own will not challenge the domi-
nant position methadone holds in treating heroin dependence.
The community sector has been strong in analysing the structural causes that 
impact on drug use in marginalised communities and also in lobbing and nego-
tiating for more services, but in the process may have become disempowered 
by their uncritical acceptance of the assumptions of medicine and psychiatry 
in treating addiction. Many communities are feeling tired and disempowered 
by the lack of progress in implementing the National Drugs Strategy (National 
Drugs Strategy, 2001). While the strategy has been successful in increasing the 
number of people on methadone to 7,074 by May 2004, it has also created a 
treatment bottleneck. 
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This paper seeks to unmask the medical hegemony behind methadone treat-
ment, question some of the evidence that emerges through the methodology 
of evidence based medicine and cast doubt on some of its claims for effective-
ness.Clearly methadone should form part of treatment for dependent heroin 
users in the context of real multi-disciplinary teams, organisations and com-
munities, which are not subjugated or eclipsed by one profession or philoso-
phy to the exclusion of others. The problem is not methadone itself, but the 
way in which the medical profession continues to dominate and control how 
addiction is defined and treated. Following on from this critique, I will examine 
the case of the Crinan project and outline some of the ways it has managed to 
counter the hegemony of medicine and integrate adult and community edu-
cation with medical and psychotherapeutic models of treatment. First, let us 
look at what has happened to addiction treatment under the dominance of the 
biomedical discourse.
Addiction treatment under the biomedical discourse
Dominant beliefs about how addiction research should be conducted are con-
structed through the philosophy of positivism and the scientific method. By 
applying statistical techniques to test competing theories positivism asserts that 
it is possible to uncover the laws of nature and produce objective ontological 
truths about the world. Positivism has played a central role in advancing the 
agenda of biomedicine and ensuring its continued dominance.
The biomedical discourse became dominant early in the twentieth century and 
continues to exercise control over how we define and understand illness, disease 
and treatment. According to Baer (2001) a combination of economic growth, 
social change and the discovery of germ theory and other medical advances 
gave biomedicine a greater political and economic advantage over other forms 
of medicine in what was a pluralistic field of practice that included homeopathy, 
botanic medicine and osteopathy. Discourses like biomedicine are maintained 
through hegemony, a process that explains how dominant classes persuade sub-
ordinate ones to accept, adopt and internalise their values and norms through 
structural rather than coercive means (Gramsci, 1971).
Along with securing a hegemony over medical practice, biomedicine extended 
its influence into psychology and addiction through the practice of psychiatry. 
As a medical specialty, psychiatry’s primary goal is to treat mental illness and 
behavioural disorders such as substance dependence, clinical depression, bipo-
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lar disorder, schizophrenia and anxiety disorders. A great deal of psychiatric 
research has been carried out to try and determine the influence of biochemical 
imbalances and genetic influences on various mental illnesses. Psychiatry holds 
that these biochemical imbalances can be corrected, changed or controlled 
through a chemical intervention in the form of a psychiatric drug (Davies and 
Bhugra, 2004).
There have been criticisms of the scientific method of psychiatric classifica-
tion with specific criticisms of the Diagnostic and Statistical Manual (DSM) 
(American Psychiatric Association, 1994) the dominant system for the clas-
sification of mental disorders and diseases including addiction and substance 
use dependency (Crowe, 2000). According to Duffy, Gillig, Tureen and Ybarra’s 
(2002), critique of the DSM is part of a larger debate about the major competing 
theories of knowledge or paradigms of positivism and social constructivism. 
When science reigns and medicine and the governments are united in a ther-
apeutic state, people perceive countless human problems as the products of 
diseases and seek to remedy them with medical interventions such as drugs. 
(Szasz, 2001, p. xxiii)
Psychiatry has been criticised for its over-reliance on psychiatric drugs and its 
close links with the pharmaceutical industry. Prescription-related disease is a 
pandemic according to McGavock (2004). Prescribed drugs are now a major 
cause of morbidity and mortality. McGavock argues that the uncritical applica-
tion of evidence-based medicine, unnecessary prescribing and the excessive and 
unjustified promotion of drugs has made this problem worse. The medicalisa-
tion of everyday problems has expanded the market for pharmaceutical drugs.
As a vulnerable population with higher levels of educational disadvantage her-
oin users are at greater risk of being over diagnosed and over prescribed. Access 
to addiction treatment data or to participants in treatment is strictly controlled 
by psychiatrists who have a vested interest in the outcomes of any research in 
this area. Evidence based medicine (EBM) is the dominant scientific methodol-
ogy employed to examine addiction treatment and is central to the continued 
dominance of the biomedical discourse in the treatment of addiction. Studies 
are generally designed, monitored and controlled by a consultant psychiatrist 
or clinical psychologist and are published in prominent medical journals.
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Evidence-based medicine
EBM uses techniques from science and statistics, such as meta-analysis of scien-
tific literature, risk-benefit analysis, and randomised controlled trials to inform 
healthcare professionals to make better decisions regarding current best evi-
dence in their everyday practice. However, EBM continues to provoke debate and 
has been criticised on for its over reliance on positivism, its narrow definition of 
evidence and its inability to integrate other non statistical data such as profes-
sional experience and patient specific factors (Sehon and Stanley, 2003). Jones 
and Sagar (1995) argue that EBM can only answer those questions for which it 
is suited and often clinically important details may be hidden, overlooked or 
simply ‘averaged out’ by the methods of the study. Studies can be designed to 
produce certain outcomes making it easier for sponsors to purchase the results 
they seek. EBM research strongly influences what research is conducted, who 
receives funding, who conducts the research and what research is published.
Questions that could potentially present aspects of addiction treatment nega-
tively are less likely to be funded from government or industrial sources and 
unlikely to be published in medical journals. Editors of medical journals play a 
central role in the promotion or suppression of ideas in medicine (Miettinen, 
1999). In addition, pressures on researchers to succeed, to publish and to bring 
in increased funding or to meet the expectations of governments appears to be 
increasing and may be a contributory factor (Breen, 2003).
Random Control Trials (RCT), the gold standard of EBM, are expensive 
to run and so researchers often turn to the pharmaceutical industry to fund 
research trials. Recent studies have demonstrated a statistically significant asso-
ciation between industry funding and authors’ conclusions in medical RTCs 
(Djulbegovic, Lacevic, Cantor, Fields, Bennett, Adams, Kuderer and Lyman, 
2000). It is clear that clinical research sponsored by the pharmaceutical industry 
impacts on how doctors practice medicine. Physicians are affected by their inter-
actions with the pharmaceutical industry. There are extensive ties between the 
pharmaceutical manufacturers and clinical researchers (Blumenthal, Lambert 
and Jenny-Avital, 2004). This relationship has a significant effect on the research 
process and how pharmaceutical products are represented and marketed.
EBM and methadone
EBM is the dominant framework within which researchers have evaluated 
methadone maintenance treatment (MMT) which has been the gold standard 
treatment for heroin addiction for nearly 40 years and is generally claimed to be 
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‘effective’. However, there is an absence of independent research with most of 
the EBM studies supporting the efficacy of MMT coming from medical sources 
with a vested interest in presenting evidence in such a way that any negative or 
unfavorable findings are obscured. This raises questions about the real effec-
tiveness of MMT.
MMT has been generally associated with a reduction in criminal activity among 
individuals participating in treatment (Rothbard, Alterman, Rutherford, Liu, 
Zelinski and McKay, 1999). However, calculating this reduction is complex 
and much of the evidence comes from small-scale studies affected by selec-
tion bias where programmes have high dropout rates resulting in exaggerated 
programme effects. Recent studies have been more cautious in their claims 
for MMT.
Unemployment remains a common problem among methadone patients 
with vocational training having no significant impact on employment (Zanis, 
Coviello, Alterman and Appling, 2001). Segest, Mygind and Bay (1990) found 
in their study an 87 per cent unemployment rate among a cohort of methadone 
patients and found no clear relationship between MMT and improved employ-
ment. Lidz, Sorrentino, Robison and Bunce (2004) examined three models of 
vocational training, none of which improved employment or rehabilitation 
rates. Peters and Reid (1998) examining methadone treatment in Scotland 
found no improvement in employment status. Studies on the impact of MMT 
on employment from within psychiatry tend to report better results (Drake, 
McHugo, Bebout, Becker, Harris, Bond and Quimby, 1999).
According to Hickman, Madden, Henry, Baker,Wallace, Wakefield, Stimson 
and Elliott (2003) MMT is associated with a decrease in mortality among drug 
users in treatment. However, methadone remains a significant factor in the 
number of drug related deaths, which mortality statistics tend to under-report 
or fail to reflect the wider causes of deaths associated with methadone or side 
effects of prescribed and non prescribed poly drug use. Studies have shown that 
the proportion of accidental overdose deaths attributed to methadone alone 
can differ substantially. While the factors associated with accidental overdose 
are complex and usually related to a combination of factors, there is reason to 
be concerned with the number of deaths associated with methadone. The fact 
that many patients continue to use a combination of drugs including heroin, 
cocaine, cannabis, alcohol and benzodizapines in addition to their prescribed 
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methadone gives cause for concern. An Irish study of 851 patients in North-
Dublin, carried out by the Royal College of Surgeons in Ireland (Royal College 
of Surgeons Ireland, 2006) found that 77 per cent of methadone patients had a 
history of cocaine use while in treatment. Many patients terminate their treat-
ment prematurely and return to regular drug use. Peters and Reid (1998) found 
in their study that only 39 per cent remained in treatment for at least 12 months. 
Fischer, Rehm, Kim and Kirst (2005) in their review found that evidence of 
MMT’s effectiveness on primary treatment objectives is mixed and appears 
to be largely short-term. They conclude that the quality and methodological 
standards of the evidence of the effectiveness of MMT are limited and far less 
impressive than usually presented.
It is clear from this analysis of the biomedical discourse and the methodology 
of evidence based medicine that supports the efficacy of methadone treatment, 
that psychiatry should not be allowed exclusive access or control of this research 
domain. There is a need for greater transparency and partnership in how treat-
ment programmes for drug users are designed, managed and evaluated. While 
within medicine there is a move towards a holistic model of treatment, this 
move is constrained by the dominance and power of the biomedical discourse 
and the control exerted by psychiatrists over addiction treatment in Ireland.
One project that has managed to develop a more holistic approach to treatment 
is the Crinan project in the north inner city of Dublin. 
Adult and community education in practice: The Crinan project
The Crinan project was established in 1997 in response to the needs of young 
adults seeking treatment for addiction to heroin and other drugs in the north 
inner city of Dublin. Managed by a partnership between the statutory sector, the 
local community and a voluntary group, the project has managed to combine 
and integrate an adult and community education approach with medical and 
psychotherapeutic models of treating heroin and cocaine addiction. In examin-
ing the Crinan project as a model of good practice in drug treatment, I will seek 
to outline how adult and community education is an effective component of 
treatment that works in a way that the medical model does not. 
Community development 
Medicine is limited to treating the symptoms of addiction. A community devel-
opment approach tackles the causes of addiction. It recognises that the deeper 
systemic causes of addiction must be addressed, if the benefits of treatment are 
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to be sustainable. Crinan is a community-based project rooted in the princi-
ples of community development, working in partnership with other organisa-
tions and professionals seeking to bring about long-term community change. 
The project participates in and is represented on various networks and poli-
cy fora influencing policy at local and national levels. As a community based 
project, its analysis of the drug problem looks at the broader causes of addic-
tion and addresses these through adult education and community develop-
ment. Addressing socio-environmental, cultural and economic factors, as well 
as demographic variables such as gender, age and ethnicity is central to this 
approach. Addressing issues of educational disadvantage, economic and social 
development as well as the provision of adequate housing, recreational facilities 
and parks is central to building communities where people have choices other 
than to use heroin or methadone. 
Community education 
Medicine requires compliance. Within the medical model, the patient normally 
becomes a passive recipient and consumer of treatment. As a result, a depen-
dency is created between the patient, the doctor and the medicine. Adult and 
community education nurtures a degree of resistance to oppressive discourses 
and an awareness of relationships based on imbalances of power or knowledge.
It seeks to enable the patient to become an active participant in their own treat-
ment and rehabilitation process. Barr (1999) suggests that community edu-
cation, a process of generating liberating knowledge is central to the way the 
project engages the local community by promoting fresh thinking, new ideas 
and directions and by placing a greater focus on the systemic and socio-eco-
nomic circumstances and variables that shape addiction. In Crinan, family sup-
port and education groups have been central to this approach. Working with 
a Parents’ Group on changing the family diet or on managing family pain in a 
non-medical or addictive way, may have a more sustainable and postive effect 
on the family system or the life of their son or daughter, than a psychological or 
counselling session.
Bancroft, Carty, Cunningham-Burley and Beckett-Milburn (2003) have shown 
that support for families of drug users is an integral part of the treatment process 
and has been shown to be effective. The family is a critical part of the socialisa-
tion process for young people and has the potential to guide young people away 




Medicine treats the pain and numbs the emotions. The pharmaceutical indus-
try profits from producing medicines that are supposed to regulate or control 
the emotions of unhappy, sad or depressed people. Art provides a way for people 
to come to terms with emotional conflicts, increase self-awareness, and express 
unspoken and often unconscious concerns about their illness and their lives. 
The Crinan project engages its participants through art in the form of ceram-
ics, mosaics, paintwork, woodwork and music production. There are no limits 
on the type of art involved. The mosaics in fact, now form part of the interior 
design of the project, creating a warm, welcoming and open environment. The 
Project’s art programme is actively helping to create a treatment space, which 
is very different from the impersonal and clinical environment that is found 
in the medical led methadone clinics. Arts education provides adults with new 
contexts for learning, understanding and for constructing new ways of being. 
It promotes a way of learning and reflecting that focuses on the creative pro-
cess. The majority of those who have become involved with heroin use have 
had negative experiences of education and have left school early. Arts educa-
tion works by facilitating adults to become self-directed learners, to find and 
apply solutions to their problems and to construct their own pathways out of 
the addiction cycle. Finlay (2000) documented similar work carried out in the 
Soilse project where they also used art in an adult and community education 
context to promote recovery and rehabilitation. 
Theatre as adult education 
Medicine has become confused with health with more and more people relying 
on medicine, doctors and hospitals for better health. The expanding medical sys-
tem is unable to meet the demands being placed on it. In the same way the drug 
addiction system is becoming overly reliant on doctors, clinics and medicine 
with more and more people remaining dependent on methadone. The Crinan 
project has tried to counter the over medicalisation of addiction treatment by 
applying the works of Boal (1979) and Freire (1972) in both conscientizing and 
empowering participants to become more aware of the connections between 
the external and internal oppressions that influence decisions to use drugs. Boal 
(1995) has demonstrated the effectiveness of theatre as a site for transforma-
tive learning among adults experiencing alienation, depression, addiction or 
any kind of personal oppression. The theatre programme has helped partici-
pants to engage more proactively in treatment and the issues that affected their 
daily lives. O’Brien (2004) applied these techniques as research methodology 
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in his qualitative study of the Crinan project which looked at drug treatment 
discourses. He found that while the biomedical discourse dominated the treat-
ment of heroin addiction in Ireland, the Crinan project had managed to hold a 
different balance between the treatment discourses of medicine, psychotherapy 
and adult education resulting in the development of a more integrated model 
of treatment. 
Alternative and complementary holistic treatments 
Access to medicine is limited and treatments are expensive and sometimes 
exclusive. The cost of health care is rising and low-income earners are often 
excluded. The growing awareness of the limited effectiveness of medicine in 
certain domains and its increasing cost, has led many people to turn to alter-
native and complementary medicine. Alternative and complementary holistic 
treatments have become part of Crinan’s integrated programme of options that 
includes methadone. Treatments include auricular acupuncture, yoga, herbal 
therapy and massage. Combining the biomedical approach of methadone sub-
stitution with holistic treatments has enabled the project to maintain a com-
paratively low methadone dose. In an environment where addiction treatment 
is highly medicalised, the Crinan project has been innovative in educating par-
ticipants, parents and staff members to seek alternative ways to respond to the 
pain and stress associated with detoxification. The project has created an envi-
ronment of detoxification rather than long-term medicalisation, which is the 
case in many of the methadone clinics. The educational sessions are designed 
to reflect the various core components of the treatment philosophy in Crinan. 
All sessional, educational and psychotherapeutic staff come together at regular 
intervals throughout the year, to review the practice and delivery of this treat-
ment model which integrates psychotherapy and adult education. 
Conclusion 
What one may ask makes adult and community education work, in a way that 
medicine does not, in treating drug addiction? Medicine alone treats the pain. 
Adult and community education engages the non-medicated part of the person 
and invites them to become an active participant in their own treatment and 
rehabilitation process. Medicine does what a drug like heroin does; it numbs 
the pain, treats the symptoms and gives temporary relief. Adult and community 
education, on the other hand, conscientizes the person to the causes of their 
drug use problem and equips them with the knowledge and skills required to 
re-engage with their problems and their underlying causes. This process does 
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not exclude medicine, but shifts the focus to a process of dynamic engagement 
with a menu of treatments and options facilitated by a multi-disciplinary team 
that is not dominated by one knowledge tradition. The Crinan project is cur-
rently conducting a qualitative research project in the form of an outcome study 
to test what it believes to be significant findings based its own observations and 
project data. 
Thomas O’Brien has spent 15 years working with early school leavers and drug users. 
In 1997 he helped establish and manage the Crinian Project in the north inner city of 
Dublin. He also spent two years managing a multi-disciplinary team working with 
mainly homeless teenagers in The Drug Treatment Board in Dublin before moving 
to Spain. 
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